202 related articles for article (PubMed ID: 27256430)
1. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
[TBL] [Abstract][Full Text] [Related]
3. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).
Hallowell N; Lawton J; Badger S; Richardson S; Hardwick RH; Caldas C; Fitzgerald RC
J Genet Couns; 2017 Aug; 26(4):752-762. PubMed ID: 27837291
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
5. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management.
Hoskins C; Tutty E; Purvis R; Shanahan M; Boussioutas A; Forrest L
J Genet Couns; 2022 Feb; 31(1):242-251. PubMed ID: 34265132
[TBL] [Abstract][Full Text] [Related]
6. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
[TBL] [Abstract][Full Text] [Related]
9. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'.
Liu Y; Calzone K; Fasaye GA; Quillin J
J Genet Couns; 2021 Aug; 30(4):1091-1104. PubMed ID: 33655597
[TBL] [Abstract][Full Text] [Related]
10. CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract][Full Text] [Related]
11. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
Kumar S; Long JM; Ginsberg GG; Katona BW
World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
13. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.
Seevaratnam R; Coburn N; Cardoso R; Dixon M; Bocicariu A; Helyer L
Gastric Cancer; 2012 Sep; 15 Suppl 1():S153-63. PubMed ID: 22160243
[TBL] [Abstract][Full Text] [Related]
16. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
17. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.
Lynch HT; Kaurah P; Wirtzfeld D; Rubinstein WS; Weissman S; Lynch JF; Grady W; Wiyrick S; Senz J; Huntsman DG
Cancer; 2008 Jun; 112(12):2655-63. PubMed ID: 18442100
[TBL] [Abstract][Full Text] [Related]
18. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
[TBL] [Abstract][Full Text] [Related]
19. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.
Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC
Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763
[TBL] [Abstract][Full Text] [Related]
20. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
Black MD; Kaneshiro R; Lai JI; Shimizu DM
Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]